NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-138-2017-0-NZ-05 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS NZ National Stage 747047 Pending
NIDDK E-138-2017-0-EA-04 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS EA National Stage 201892008 Pending
NIDDK E-138-2017-0-BR-07 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS BR National Stage BR112018071560-3 Pending
NIDDK E-138-2017-0-AU-01 COMPOUNDS AND METHODS FOR TREATING BRAIN INJURY AU DIV 2023202694 Pending
NCI E-131-2016-0-JP-06 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO JP National Stage 2018-555639 Issued
NCI E-131-2016-0-PCT-02 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO PCT PCT PCT/US2017/028628 Expired
NCI E-131-2016-0-CA-04 EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO CA National Stage 3021569 Pending
NCI E-269-2010-0-JP-11 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE JP DIV 2065-08-29 Abandoned
NIAID E-099-2016-0-EP-08 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS EP National Stage 17723547.0 Issued
NIAID E-099-2016-0-KR-11 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS KR National Stage 10-2018-7033500 Issued
NIAID E-099-2016-0-AU-05 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS AU National Stage 2017253935 Abandoned
NIAID E-145-2015-3-EP-03 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV EP National Stage 15841780.8 Issued
NIAID E-145-2015-3-IE-11 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV IE EP 15841780.8 Issued
NIAID E-145-2015-3-IT-12 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV IT EP 15841780.8 Issued
NIAID E-145-2015-3-ES-08 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV ES EP 15841780.8 Issued
NIAID E-145-2015-3-NL-13 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV NL EP 15841780.8 Issued
NIAID E-145-2015-3-CH-06 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV CH EP 15841780.8 Issued
NIAID E-145-2015-3-GB-10 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV GB EP 15841780.8 Issued
NIAID E-145-2015-3-FR-09 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV FR EP 15841780.8 Issued
NIAID E-145-2015-3-DE-07 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV DE EP 15841780.8 Issued
NIAID E-099-2016-0-PCT-02 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS PCT PCT PCT/US2017/028133 Expired
NIAID E-099-2016-0-HK-20 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS HK EP 19127785.4 Issued
NIAID E-099-2016-0-IL-09 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS IL National Stage 262455 Issued
NIAID E-099-2016-0-CA-06 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CA National Stage 3020863 Abandoned
NIAID E-099-2016-0-CN-07 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS CN National Stage 201780038148.6 Issued
NIAID E-099-2016-0-SG-13 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS SG National Stage 11201809100Q Abandoned
NIAID E-099-2016-0-MX-12 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS MX National Stage MX/a/2018/012719 Abandoned
NIAID E-099-2016-0-JP-10 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS JP National Stage 2018-553392 Abandoned
NCI E-263-2011-0-US-09 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC B CELL EPITOPES US DIV 15/488,898 10111927 Issued PDF
NCI E-308-2000-0-US-16 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US CON 15/489,130 Abandoned
NCI E-153-2016-0-PCT-02 ANTI-KK-LC-1 T CELL RECEPTORS PCT PCT PCT/US17/027865 Expired
NCI E-153-2016-0-CA-04 ANTI-KK-LC-1 T CELL RECEPTORS CA National Stage 3021898 Pending
NINDS E-146-2016-1-PCT-01 Selective D3 Dopamine Receptor Agonists and Methods of Their Use PCT PCT PCT/US2017/027618 Expired
NCI E-242-2015-1-JP-05 Peptide-Based Methods For Treating Pancreatic Cancer JP National Stage 2017-540549 Pending
NCI E-257-2009-1-US-20 Heterodimers of IL-15 and IL-15R Alpha to Increase Thymic Output and to Treat Lymphopenia US CON 15/485,093 10093710 Issued PDF
NCI E-290-2006-2-US-35 MICRO-RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COLON CANCER-RELATED DISEASES US DIV 15/484,446 Abandoned
NLM E-107-2010-2-US-13 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/483,282 10612076 Issued PDF
NCI E-242-2015-1-US-07 Peptide-Based Methods For Treating Pancreatic Cancer US National Stage 15/518,216 10016480 Issued PDF
NLM E-107-2010-2-US-14 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/483,297 Pending
NLM E-111-2016-8-US-01 Novel CRISPR Enzymes And Systems US CIP 15/482,603 110601152 Issued PDF
NCI E-263-2014-0-US-06 METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47 US National Stage 15/517,345 11053314 Issued PDF
NHLBI E-165-2014-1-IE-09 Lentiviral Vector for Treating Hemoglobin Disorders IE EP 15757074.8 Issued
NHLBI E-165-2014-1-CH-05 Lentiviral Vector for Treating Hemoglobin Disorders CH EP 15757074.8 Issued
NHLBI E-165-2014-1-GB-08 Lentiviral Vector for Treating Hemoglobin Disorders GB EP 15757074.8 Issued
NHLBI E-165-2014-1-DE-06 Lentiviral Vector for Treating Hemoglobin Disorders DE EP 15757074.8 Issued
NHLBI E-165-2014-1-FR-07 Lentiviral Vector for Treating Hemoglobin Disorders FR EP 15757074.8 Issued
NIAID E-142-2016-0-PCT-02 FRANCISELLA LIPIDS AS BROAD ANTI-INFLAMMATORY THERAPEUTICS AND ASSOCIATED METHODS OF USE PCT PCT PCT/US2017/026467 Expired
NCI E-132-2016-2-PCT-01 Use Of Heterodimeric IL-15 In Adoptive Cell Transfer PCT PCT COMB PCT/US17/026447 Expired
NCI E-340-2007-0-US-16 Human Prostate Cancer MicroRNA Signature US DIV 15/480,753 Abandoned
NIAID E-142-2016-0-EP-03 FRANCISELLA LIPIDS AS BROAD ANTI-INFLAMMATORY THERAPEUTICS AND ASSOCIATED METHODS OF USE EP National Stage 17721893.0 Pending